An Algorithm for Individual Dosage in Cadmium-Zinc-Telluride SPECT-Gated Radionuclide Angiography

• Published in: Diagnostics (Basel) Vol. 11; no. 12; p. 2268
• Main Authors: Hansen, Maria Normand, Haarmark, Christian, Kristensen, Bent, Zerahn, Bo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04-12-2021; MDPI
• Subjects: Algorithms; Cardiac function; Chemotherapy; CZT SPECT; gated SPECT; Medical imaging; Patients; personalised medicine; Radiation; RNA; Software; United States > US; gated SPECT; personalised medicine; RNA; CZT SPECT
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics11122268

The aim of the present study was to test an individualised dose without compromising the ease of analysing data when performing equilibrium radionuclide angiography (ERNA) using cadmium-zinc-telluride (CZT) SPECT. From March 2018 to January 2019, 1650 patients referred for ERNA received either an individualised dose of
Tc-labeled human serum albumin (HSA) according to their age, sex, height, and weight (
= 1567), or a standard dose of 550 MBq (
= 83). The target count rate (CR
) was reduced every two months from 2.7 to 1.0 kcps. A final test with a CR
of 1.7 kcps was run for three months to test whether an agreement within 2% points for the determination of LVEF, on the basis of only two analyses, was obtainable in at least 95% of acquisitions. All the included ERNAs were performed on a dedicated cardiac CZT SPECT camera. When using the algorithm for an individualised dose, we found that agreement between the measured and predicted count rate was 80%. With a CR
of 1.7 kcps, the need for more than two analyses to obtain sufficient agreement for LVEF was 4.9%. Furthermore, this resulted in a mean dose reduction from 550 to 258 MBq. Patients' weight, height, sex, and age can, therefore, be used for individualising a tracer dose while reducing the mean dose.